Lancet. 1977 Jun 4;1(8023):1176-8.

Type-III Hyperlipoproteinaemia ("remnant removal disease"). Insight into the pathogenetic mechanism.

Chait A, Brunzell JD, Albers JJ, Hazzard WR.

Abstract

The metabolism of very-low-density lipoprotein (V.L.D.L.) was studied in a patient with type-III hyperlipoproteinaemia. After injection of radioiodinated V.L.D.L. from a donor with endogenous hypertriglyceridaemia (in a type-IV pattern), clearance of radioactivity from the apoprotein-B moiety of V.L.D.L. was slow and appearance in low-density lipoprotein (L.D.L.) was delayed, suggesting defective catabolism of V.L.D.L. in type-III hyperlipoproteinaemia. Despite a 60% increase in the rate of V.L.D.L. production, therapy with oestrogen (ethinyloestradiol 1 microng/kg/day) resulted in a decrease in plasma-lipid concentrations, normalisation of lipoprotein composition, and correction of the defect in V.L.D.L. catabolism with increased conversion to L.D.L. Thus, in type-III hyperlipoproteinaemia, the primary defect seems to be impaired catabolism of V.L.D.L., which is corrected with oestrogen therapy.

PMID:: 68276; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Molecular Biology Databases

CHOLESTEROL - HSDB

Supplemental Content

Save items

Related citations in PubMed

The metabolism of low density lipoprotein in endogenous hypertriglyceridaemia. [Eur J Clin Invest. 1976]
The metabolism of low density lipoprotein in endogenous hypertriglyceridaemia.
Sigurdsson G, Nicoll A, Lewis B. Eur J Clin Invest. 1976 Mar 31; 6(2):151-8.
[Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)]. [Klin Wochenschr. 1977]
[Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)].
Weisweiler P, Schwandt P. Klin Wochenschr. 1977 Aug 15; 55(16):791-4.
Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins. [Metabolism. 2001]
Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
Marcoux C, Tremblay M, Fredenrich A, Davignon J, Cohn JS. Metabolism. 2001 Jan; 50(1):112-9.
Review Abnormalities in metabolism of low density lipoproteins associated with coronary heart disease. [Acta Med Scand Suppl. 1985]
Review Abnormalities in metabolism of low density lipoproteins associated with coronary heart disease.
Grundy SM, Vega GL, Kesäniemi YA. Acta Med Scand Suppl. 1985; 701:23-37.
Review A simplified approach to lipoprotein kinetics and factors affecting serum cholesterol and triglyceride concentrations. [Am J Clin Nutr. 1981]
Review A simplified approach to lipoprotein kinetics and factors affecting serum cholesterol and triglyceride concentrations.
Hopkins PN, Williams RR. Am J Clin Nutr. 1981 Nov; 34(11):2560-90.

See reviews... See all...

Cited by 11 PubMed Central articles

LDL composition in E2/2 subjects and LDL distribution by Apo E genotype in type 1 diabetes. [Atherosclerosis. 2007]
LDL composition in E2/2 subjects and LDL distribution by Apo E genotype in type 1 diabetes.
Murdoch SJ, Boright AP, Paterson AD, Zinman B, Steffes M, Cleary P, Edwards K, Marcovina SS, Purnell JQ, Brunzell JD, et al. Atherosclerosis. 2007 May; 192(1):138-47. Epub 2006 Jun 5.
Sex steroid modulation of fatty acid utilization and fatty acid binding protein concentration in rat liver. [J Clin Invest. 1980]
Sex steroid modulation of fatty acid utilization and fatty acid binding protein concentration in rat liver.
Ockner RK, Lysenko N, Manning JA, Monroe SE, Burnett DA. J Clin Invest. 1980 May; 65(5):1013-23.
Degradation of lipoproteins by human monocyte-derived macrophages. Evidence for two distinct processes for the degradation of abnormal very-low-density lipoprotein from subjects with type III hyperlipidaemia. [Biochem J. 1984]
Degradation of lipoproteins by human monocyte-derived macrophages. Evidence for two distinct processes for the degradation of abnormal very-low-density lipoprotein from subjects with type III hyperlipidaemia.
Soutar AK, Knight BL. Biochem J. 1984 Feb 15; 218(1):101-11.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound
PubChem chemical compound records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records. Multiple substance records may contribute to the PubChem compound record.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Gene (OMIM)
Gene records associated with Online Mendelian Inheritance in Man (OMIM) records that cite the current articles in their reference lists.
Nucleotide (Weighted)
Nucleotide records associated with the current articles through the Gene database. These are the related sequences on the Gene record that are added manually by NCBI.
OMIM (calculated)
Online Mendelian Inheritance in Man (OMIM) records that include the current articles as references in the light bulb links within or in the citations at the end of the OMIM record. The references available through the light bulb link are collected using the PubMed related articles algorithm to identify records with similar terminology to the OMIM record.
OMIM (cited)
Online Mendelian Inheritance in Man (OMIM) records that include the current articles as reference cited at the end of the OMIM record.
Protein (Weighted)
Protein records associated with the current articles through related Gene database records. These are the related sequences on the Gene record that are added manually by NCBI.
Substance
PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Type-III Hyperlipoproteinaemia ("remnant removal disease"). Insight into the pat...
Type-III Hyperlipoproteinaemia ("remnant removal disease"). Insight into the pathogenetic mechanism.
Lancet. 1977 Jun 4 ;1(8023):1176-8.

PubMed
Cystic fibrosis screening by dried blood spot trypsin assay: results in 75,000 n...
Cystic fibrosis screening by dried blood spot trypsin assay: results in 75,000 newborn infants.
J Pediatr. 1983 Mar ;102(3):383-7.

PubMed
Parental perceptions of child behavior problems, parenting self-esteem, and moth...
Parental perceptions of child behavior problems, parenting self-esteem, and mothers' reported stress in younger and older hyperactive and normal children.
J Consult Clin Psychol. 1983 Feb ;51(1):86-99.

PubMed
Charles Peter Mills.
Charles Peter Mills.
Lancet. 1977 May 28 ;1(8022):1164-5.

PubMed
Regulation of the fasting enterohepatic circulation of bile acids by the migrati...
Regulation of the fasting enterohepatic circulation of bile acids by the migrating myoelectric complex in dogs.
J Clin Invest. 1983 Mar ;71(3):644-54.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Type-III Hyperlipoproteinaemia ("remnant removal disease"). Insight into the pathogenetic mechanism.

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 11 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information